当前位置: 首页 >> 检索结果
共有 38571 条符合本次的查询结果, 用时 6.0164855 秒

2001. A 17-Year-Old Girl Diagnosed With STING-Associated Vasculopathy With Onset in Infancy (SAVI) After Lung Transplantation.

作者: Dohyung Kim.;Kun Baek Song.;Eom Ji Choi.;Jinho Yu.
来源: Chest. 2022年162卷5期e249-e252页
A 17-year-old girl received lung transplantation after chronic respiratory failure. She developed a fever (> 38 °C) once or twice weekly starting 2 months after surgery, and multiple papulopustules on the skin waxed and waned for 4 months. She then developed blood-tinged sputum. She had been treated with triple immunosuppressants, including prednisolone, tacrolimus, and mycophenolate mofetil after lung transplantation, and her symptoms appeared during prednisolone dose reduction.

2002. A Case of Thrombotic Microangiopathy and Acute Sarcoidosis.

作者: Anthony W Martinelli.;William Dunn.;Mark E McClure.;Ieuan Walker.;Andrew Stewart.;Sumit Karia.;Stephen D Preston.;Sathia Thiru.;Nicholas Torpey.;Sanjay Ojha.;Emily Symington.;James A Nathan.
来源: Chest. 2022年162卷5期e245-e248页
Although sarcoidosis is an established cause of multiorgan dysfunction, acute presentation with thrombotic microangiopathy resulting in severe renal and hematological sequelae has not been reported. We describe the case of a patient presenting with hypercalcemia, pancreatitis, and acute renal failure, followed by microangiopathic hemolytic anemia. Although there were no significant respiratory symptoms, thoracic radiology and mediastinal lymph node biopsy results were in keeping with sarcoidosis as the underlying cause of this multisystem presentation. Corticosteroids were commenced with clinical and biochemical improvement. This novel case highlights the need to consider sarcoidosis as part of the differential diagnosis for unusual multiorgan presentations and for early multidisciplinary involvement in such cases to permit optimal treatment.

2003. Why Sepsis Survivors Need an ICD-10 Code for "Sepsis Aftercare".

作者: Sungho Oh.;Mark E Mikkelsen.;Melissa O'Connor.;Kathryn H Bowles.
来源: Chest. 2022年162卷5期979-981页

2004. Rebuttal From Dr Keir and Prof Chalmers.

作者: Holly R Keir.;James D Chalmers.
来源: Chest. 2022年162卷5期977-978页

2005. Rebuttal From Drs Martinez-Garcia and Agusti.

作者: Miguel Ángel Martínez-García.;Alvar Agusti.
来源: Chest. 2022年162卷5期976-977页

2006. COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? No.

作者: Holly R Keir.;James D Chalmers.
来源: Chest. 2022年162卷5期972-976页

2007. POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes.

作者: Miguel Ángel Martínez-García.; Alvar Agusti.
来源: Chest. 2022年162卷5期970-972页

2008. Not all Blebs Are Created Equal.

作者: Preeti Gupta.;Christopher M Kapp.
来源: Chest. 2022年162卷5期968-969页

2009. Welcome to the Real World: Understanding the Many Faces of Osimertinib-Related Pneumonitis.

作者: Jennifer D Possick.
来源: Chest. 2022年162卷5期965-967页

2010. Preoperative Biopsy Does Not Generate STAS?

作者: Hironori Uruga.;Mari Mino-Kenudson.
来源: Chest. 2022年162卷5期963-964页

2011. Treatment of Intranasal Corticosteroids for OSA Syndrome: Is the Juice Worth the Squeeze?

作者: Fauziya Hassan.;Kristie Ross.
来源: Chest. 2022年162卷5期961-962页

2012. Time to Use Direct Oral Anticoagulants to Prevent Recurrences and Major Acute Cardiovascular Events After VTE?

作者: Cecilia Becattini.;Maria Cristina Vedovati.
来源: Chest. 2022年162卷5期959-960页

2013. The Value of Cardiopulmonary Exercise Testing as a Predictor of Mortality in Heart Failure.

作者: Richard Casaburi.
来源: Chest. 2022年162卷5期957-958页

2014. Obesity and Sarcoidosis Risk: An Index Under Suspicion.

作者: Yvette C Cozier.;Praveen Govender.;Jeffrey S Berman.
来源: Chest. 2022年162卷5期954-956页

2015. Septic Shock in Patients With Solid Malignancies: What Does the Host Response Yield When the Host Is Already Under Threat?

作者: Patrick G Lyons.;Colleen A McEvoy.
来源: Chest. 2022年162卷5期951-953页

2016. What End-of-Life Communication in ICUs Around the World Teaches Us About Shared Decision-Making?

作者: Komal Patel Murali.;May Hua.
来源: Chest. 2022年162卷5期949-950页

2017. Single vs Multiple Inhaler Triple Therapy in the COPD Population.

作者: Eunice E Cho.;Andrea S Gershon.
来源: Chest. 2022年162卷5期947-948页

2018. Breathing Under Water.

作者: Aleksandra Yakhkind.
来源: Chest. 2022年162卷5期1145-1146页

2019. Prevalence and Predictors of Sleep-Disordered Breathing in Men Participating in the Multicenter AIDS Cohort Study.

作者: Naresh M Punjabi.;Todd T Brown.;R Nisha Aurora.;Sanjay R Patel.;Valentina Stosor.;Joshua Hyong-Jin Cho.;Gypsyamber D'Souza.;Joseph B Margolick.
来源: Chest. 2023年163卷3期687-696页
Data on the prevalence of sleep-disordered breathing (SDB) in people with HIV are limited. Moreover, whether the associations between SDB and age or BMI differ by HIV status is unknown.

2020. Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort.

作者: W Blake LeMaster.;P Miguel Quibrera.;David Couper.;Donald P Tashkin.;Eugene R Bleecker.;Claire M Doerschuk.;Victor E Ortega.;Christopher Cooper.;MeiLan K Han.;Prescott G Woodruff.;Wanda K O'Neal.;Wayne H Anderson.;Neil E Alexis.;Russell P Bowler.;R Graham Barr.;Robert J Kaner.;Mark T Dransfield.;Robert Paine.;Victor Kim.;Jeffrey L Curtis.;Fernando J Martinez.;Annette T Hastie.;Igor Barjaktarevic.
来源: Chest. 2023年163卷3期515-528页
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) considers blood eosinophil counts < 100 cells/μL (BEC≤100) in people with COPD to predict poor inhaled corticosteroid (ICS) responsiveness. However, the BEC≤100 phenotype is inadequately characterized, especially in advanced COPD.
共有 38571 条符合本次的查询结果, 用时 6.0164855 秒